Clinical Trial Update: Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot study comparing Protexa versus TiLoopBra for immediate breast reconstruction in breast cancer patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hereditary Breast and Ovarian Cancer Syndrome

Drugs mentioned

• Protexa
• TiLoopBra

Snippet

Sponsor: Medical University of Vienna | Conditions: Breast Cancer, Hereditary Breast and Ovarian Cancer Syndrome | Phase 4 | Status: COMPLETED